(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 30.61%79.12B | 21.74%32.44B | -9.70%127.81B | -12.84%95.12B | -16.02%60.57B | -25.05%26.65B | -13.54%141.54B | -7.70%109.13B | -1.45%72.13B | 23.19%35.56B |
Operating income | 30.61%79.12B | 21.74%32.44B | -9.70%127.81B | -12.84%95.12B | -16.02%60.57B | -25.05%26.65B | -13.54%141.54B | -7.70%109.13B | -1.45%72.13B | 23.19%35.56B |
Operating expenses | -34.76%-70.63B | -26.68%-29.14B | 8.09%-110.21B | 10.93%-82.1B | 14.36%-52.41B | 23.63%-23B | 10.63%-119.91B | 4.82%-92.18B | -0.26%-61.2B | -23.67%-30.12B |
Gross profit | 3.98%8.49B | -9.44%3.3B | -18.62%17.6B | -23.20%13.02B | -25.31%8.16B | -32.96%3.65B | -26.74%21.62B | -20.75%16.96B | -10.01%10.93B | 20.63%5.44B |
Selling expenses | -5.08%-1.19B | -4.75%-581.39M | -12.60%-2.76B | -4.96%-1.93B | 4.52%-1.13B | -0.14%-555.04M | 11.12%-2.45B | -8.61%-1.84B | -9.91%-1.18B | -14.41%-554.29M |
Administrative expenses | -11.72%-3.28B | -2.13%-1.36B | 7.23%-6.51B | 14.31%-4.43B | 13.26%-2.94B | 2.97%-1.34B | -20.88%-7.01B | -23.82%-5.17B | -20.41%-3.39B | -27.75%-1.38B |
Research and development expenses | -0.55%-1.13B | 10.25%-486.13M | 1.38%-2.43B | 1.91%-1.68B | -7.29%-1.12B | -14.93%-541.64M | -9.36%-2.46B | -19.52%-1.71B | -11.58%-1.04B | -20.20%-471.28M |
Profit from asset sales | -50.65%9.06M | 540.84%7.36M | -90.22%23.78M | 359.62%13.5M | 510.68%18.36M | 75.33%-1.67M | 1,339.15%243.25M | -104.12%-5.2M | -97.51%3.01M | -246.96%-6.77M |
Revaluation surplus | 77.81%-249.76M | -23.98%-108.24M | 43.22%-611.39M | 48.66%-844.56M | -23.53%-1.13B | 74.77%-87.31M | -1,395.34%-1.08B | -1,052.23%-1.64B | -623.71%-911.25M | 8.19%-346M |
-Changes in the fair value of other assets | 77.81%-249.76M | -23.98%-108.24M | 43.22%-611.39M | 48.66%-844.56M | -23.53%-1.13B | 74.77%-87.31M | -1,395.34%-1.08B | -1,052.23%-1.64B | -623.71%-911.25M | 8.19%-346M |
Impairment and provision | 43.23%-76.61M | -298.67%-16.38M | 13.65%-670.92M | -11.90%-168.84M | 24.65%-134.95M | 164.05%8.24M | 84.32%-776.95M | 42.00%-150.88M | 33.21%-179.09M | 10.63%-12.87M |
-Other impairment is provision | 43.23%-76.61M | -298.67%-16.38M | 13.65%-670.92M | -11.90%-168.84M | 24.65%-134.95M | 164.05%8.24M | 84.32%-776.95M | 42.00%-150.88M | 33.21%-179.09M | 10.63%-12.87M |
Special items of operating profit | 9.09%324.71M | -122.81%-74.28M | 534.24%236.22M | -270.60%-248.61M | -19.69%297.67M | -38.03%325.63M | -102.84%-54.4M | -86.95%145.73M | -60.30%370.67M | -2.58%525.44M |
Operating profit | 48.56%2.64B | -58.02%560.29M | -42.01%4.34B | -45.62%3.35B | -59.06%1.78B | -56.05%1.33B | -50.05%7.48B | -57.53%6.16B | -43.78%4.34B | 16.50%3.04B |
Financing cost | -299.24%-522.94M | 69.89%-153.31M | -6,506.82%-1.51B | -231.24%-807.34M | -213.39%-130.99M | -69.49%-509.23M | 101.56%23.52M | 158.62%615.14M | 113.98%115.51M | -7.00%-300.46M |
Special items of earning before tax | 1,348.07%100.38M | 4,199.16%86.54M | 100.40%2.26M | 102.29%12.53M | -84.45%6.93M | -79.37%2.01M | -221.47%-567.36M | -782.14%-546.59M | 247.80%44.58M | -29.85%9.76M |
Earning before tax | 34.13%2.22B | -40.36%493.52M | -59.15%2.83B | -58.98%2.56B | -63.27%1.65B | -69.87%827.56M | -47.82%6.94B | -53.50%6.23B | -34.42%4.5B | 17.37%2.75B |
Tax | -24.08%-820.93M | 21.29%-275.6M | 58.45%-970.8M | 45.76%-1.1B | 47.66%-661.59M | 51.85%-350.14M | 52.64%-2.34B | 41.04%-2.04B | 30.31%-1.26B | -23.35%-727.14M |
After-tax profit from continuing operations | 54.18%1.39B | -40.67%217.92M | -61.94%1.85B | -68.88%1.37B | -72.72%904.76M | -81.81%367.3M | -38.42%4.87B | -53.61%4.39B | -32.79%3.32B | 15.35%2.02B |
After-tax profit from non-continuing business | ---- | ---- | 103.78%10.12M | 143.80%85.62M | 204.28%85.62M | --110.12M | -158.96%-267.89M | -140.57%-195.5M | -173.74%-82.11M | ---- |
Earning after tax | 40.85%1.39B | -54.36%217.92M | -59.50%1.86B | -65.39%1.45B | -69.38%990.38M | -76.36%477.42M | -44.97%4.6B | -57.82%4.19B | -35.90%3.23B | 15.35%2.02B |
Minority profit | -10.59%529.15M | -57.67%134.28M | 4.36%1.44B | -11.20%955.83M | -14.92%591.83M | 1.39%317.25M | -18.49%1.38B | -5.97%1.08B | -7.01%695.58M | 28.70%312.89M |
Profit attributable to shareholders | 117.23%865.78M | -47.79%83.64M | -86.91%421.25M | -84.10%495.58M | -84.30%398.56M | -90.61%160.18M | -51.70%3.22B | -64.57%3.12B | -40.93%2.54B | 13.20%1.71B |
Basic earnings per share | 128.57%0.16 | -52.81%0.0126 | -88.14%0.07 | -85.46%0.083 | -89.99%0.07 | -94.35%0.0267 | -50.83%0.59 | -64.41%0.5708 | -40.07%0.6996 | 16.66%0.4726 |
Diluted earnings per share | 114.29%0.15 | -52.81%0.0126 | -91.23%0.05 | -86.68%0.0751 | -89.84%0.07 | -94.35%0.0267 | -52.50%0.57 | -64.83%0.564 | -40.93%0.6893 | 16.66%0.4726 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Auditor | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants Limited | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data